AcelRx Pharmaceuticals (ACRX) Reports Fourth Quarter And Full Year 2013 Financial Results
3/4/2014 6:24:47 AM
REDWOOD CITY, Calif., March 3, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported financial results for the three and twelve months ended December 31, 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by